Bioxcel Therapeutics Announces Completion Of Patient Enrollment In Safety Portion Of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial Of BXCL701 In Combination With KEYTRUDA®

Press/Media

Period6 Feb 2024

Media coverage

1

Media coverage

  • TitleBioxcel Therapeutics Announces Completion Of Patient Enrollment In Safety Portion Of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial Of BXCL701 In Combination With KEYTRUDA®
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date6/02/24
    PersonsSuresh Agarwal
View all 1
View less